Replies to post #123675 on Savvy Trades and Investments

[researcher59]

JAZZ +27 to 168 after reporting positive phase 3 trial data -

briefing -

Jazz Pharma reports HERIZON-GEA-01 Phase 3 results supporting Ziihera (141.07 ) : Ziihera plus chemotherapy showed a clinically meaningful and statistically significant improvement in PFS versus trastuzumab and chemotherapy, and a clinically meaningful effect with a strong trend toward statistical significance for OS at the first OS interim analysis